The elderly and cardiovascular medication

J 2012

The elderly and cardiovascular medication

MATĚJOVSKÁ KUBEŠOVÁ, Hana; Pavel WEBER; Hana MELUZÍNOVÁ a Jan MATĚJOVSKÝ

Základní údaje

Originální název

The elderly and cardiovascular medication

Autoři

MATĚJOVSKÁ KUBEŠOVÁ, Hana; Pavel WEBER; Hana MELUZÍNOVÁ a Jan MATĚJOVSKÝ

Vydání

Kuprevich Gerontological Journal, 2012, 1990-5327

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Rusko

Utajení

není předmětem státního či obchodního tajemství

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/12:00062650

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

angiotensin converting enzyme inhibitors – antiaggregants – beta-blockers – statins – calcium blockers – diuretics – digoxin – pharmacotherapy in the elderly – unwanted side effects – medical interactions

Změněno: 22. 3. 2013 15:52, Ing. Mgr. Věra Pospíšilíková

Anotace

V originále

Authors analyze actual situation in treatment of cardiovascular diseases in older patients. Different groups of recommended drugs are discussed separately, possible risks for elderly patients are stressed. Angiotensin converting enzyme inhibitors – this group is widely used in older patients because of their hypotensive effect, positive influence on cardiac failure and positive modulation of endothelial dysfunction. The risk of hyperkalemia must be considered. Antiaggregants and anticoagulants are proved as potent prophylactic treatment, but the associated risk of gastrointestinal bleeding must be weighed very carefully. Bradycardia related to beta-blockers, especially in combination with other medications lowering the heart rate must be taken into account, otherwise this group brings the highest profit in cardiovascular diseases as for morbidity and mortality. Attention is paid to calcium channel blockers, statines, diuretics, nitrates and digoxin. A table listing the possible side effects and clinical symptoms of overdose by medications most frequently used in the elderly concludes the article.

Návaznosti

MUNI/A/0814/2011, interní kód MU

Název: Prevence syndromů stáří (Akronym: PRESYST)

Investor: Masarykova univerzita, Prevence syndromů stáří, DO R. 2020_Kategorie A - Specifický výzkum - Studentské výzkumné projekty

Citovat

MATĚJOVSKÁ KUBEŠOVÁ, Hana; Pavel WEBER; Hana MELUZÍNOVÁ a Jan MATĚJOVSKÝ. The elderly and cardiovascular medication. Kuprevich Gerontological Journal. 2012, roč. 3/2012, 4-5, s. 25-31. ISSN 1990-5327.

@article{1080757,
   author = {Matějovská Kubešová, Hana and Weber, Pavel and Meluzínová, Hana and Matějovský, Jan},
   article_number = {4-5},
   keywords = {angiotensin converting enzyme inhibitors – antiaggregants – beta-blockers – statins – calcium blockers – diuretics – digoxin – pharmacotherapy in the elderly – unwanted side effects – medical interactions},
   language = {eng},
   issn = {1990-5327},
   journal = {Kuprevich Gerontological Journal},
   title = {The elderly and cardiovascular medication},
   volume = {3/2012},
   year = {2012}
}

TY  - JOUR
ID  - 1080757
AU  - Matějovská Kubešová, Hana - Weber, Pavel - Meluzínová, Hana - Matějovský, Jan
PY  - 2012
TI  - The elderly and cardiovascular medication
JF  - Kuprevich Gerontological Journal
VL  - 3/2012
IS  - 4-5
SP  - 25-31
EP  - 25-31
SN  - 19905327
KW  - angiotensin converting enzyme inhibitors – antiaggregants – beta-blockers – statins – calcium blockers – diuretics – digoxin – pharmacotherapy in the elderly – unwanted side effects – medical interactions
N2  - Authors analyze actual situation in treatment of cardiovascular diseases in older patients. Different groups of recommended drugs are discussed separately, possible risks for elderly patients are stressed. Angiotensin converting enzyme inhibitors – this group is widely used in older patients because of their hypotensive effect, positive influence on cardiac failure and positive modulation of endothelial dysfunction. The risk of hyperkalemia must be considered. Antiaggregants and anticoagulants are proved as potent prophylactic treatment, but the associated risk of gastrointestinal bleeding must be weighed very carefully. Bradycardia related to beta-blockers, especially in combination with other medications lowering the heart rate must be taken into account, otherwise this group brings the highest profit in cardiovascular diseases as for morbidity and mortality. Attention is paid to calcium channel blockers, statines, diuretics, nitrates and digoxin. A table listing the possible side effects and clinical symptoms of overdose by medications most frequently used in the elderly concludes the article.
ER  -

MATĚJOVSKÁ KUBEŠOVÁ, Hana; Pavel WEBER; Hana MELUZÍNOVÁ a Jan MATĚJOVSKÝ. The elderly and cardiovascular medication. \textit{Kuprevich Gerontological Journal}. 2012, roč.~3/2012, 4-5, s.~25-31. ISSN~1990-5327.

Přehled o publikaci